In 2023, two Correspondence published in The Lancet Infectious Diseases highlighted the growing apprehension regarding extensively drug-resistant bacteria originating from Ukraine, exacerbated by the ongoing conflict.1,2 However, there is a paucity of large granular and localised datasets to substantiate and guide international response efforts.
We report on this crucial gap by presenting findings from over 6800 diagnostic isolates obtained from the largest health-care union in Western Ukraine collated as part of development of a yearly cumulative antibiogram (CuAbgm) to track antibiotic-resistant bacteria in our region; the study period took place between May 1, 2023, and April 30, 2024. Hospitals within the First Lviv Territorial Medical Union (1TMO) contain over 2400 beds and provide treatment for more than 100 000 patients annually. 1TMO is an essential hospital union in the trauma evacuation pathway, receiving war-wounded casualties for definitive reconstruction surgery and burns treatment from other Ukrainian hospitals.